Foxa1 and Foxa2 Control the Differentiation of Goblet and Enteroendocrine L- and D-Cells in Mice

Gastroenterology

Volumn 137, Issue 6, 2009, Pages 2052-2062

  Ye, Diana Z ^a   Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6; PEPTIDE YY; PREPROGLUCAGON; SOMATOSTATIN; TRANSCRIPTION FACTOR PAX6;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLON MUCOSA; CONTROLLED STUDY; ENTEROENDOCRINE CELL; FEMALE; GOBLET CELL; IMMUNOHISTOCHEMISTRY; L CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SMALL INTESTINE MUCOSA;

EID: 70949092295     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.059     Document Type: Article

References (61)

1. Jenny M., Uhl C., Roche C., et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21 (2002) 6338-6347
2. Naya F.J., Huang H.P., Qui Y., et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroDdeficient mice. Genes Dev 11 (1997) 2323-2334
3. Larsson L.I., St-Onge L., Hougaard D.M., et al. Pax 4 and 6 regulate gastrointestinal endocrine cell development. Mech Dev 79 (1998) 153-159
4. Larsson L., Tingstedt J., Madsen O., et al. The LIM-homeodomain protein Isl-1 segregates with somatostatin but not with gastrin expression during differentiation of somatostatin/gastrin precursor cells. Endocrine 3 (1995) 519-524
5. Lee C.S., and Kaestner K.H. Clinical endocrinology and metabolism. Development of gut endocrine cells. Best Pract Res Clin Endocrinol Metab 18 (2004) 453-462
6. Yang Q., Bermingham N.A., Finegold M.J., et al. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 294 (2001) 2155-2158
7. Lee C.S., Brestelli J.E., and Kaestner K.H. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev 16 (2002) 1488-1497
8. Desai S., Loomis Z., Pugh-Bernard A., et al. Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine. Dev Biol 313 (2008) 58-66
9. Gierl M.S., Karoulias N., Wende H., et al. The zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev 20 (2006) 2465-2478
10. Katz J.P., Perreault N., Goldstein B.G., et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129 (2002) 2619-2628
11. Monaghan A.P., Kaestner K.H., Grau E., et al. Postimplantation expression patterns indicate a role for the mouse forkhead/HNF-3 alpha, beta and gamma genes in determination of the definitive endoderm, chordamesoderm and neuroectoderm. Development 119 (1993) 567-578
12. Besnard V., Wert S.E., Hull W.M., et al. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns 5 (2004) 193-208
13. Kaestner K.H., Hiemisch H., Luckow B., et al. The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics 20 (1994) 377-385
14. Vatamaniuk M.Z., Gupta R.K., Lantz K.A., et al. Foxa1-deficient mice exhibit impaired insulin secretion due to uncoupled oxidative phosphorylation. Diabetes 55 (2006) 2730-2736
15. Behr R., Brestelli J., Fulmer J.T., et al. Mild nephrogenic diabetes insipidus caused by Foxa1 deficiency. J Biol Chem 279 (2004) 41936-41941
16. Shih D.Q., Navas M.A., Kuwajima S., et al. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc Natl Acad Sci U S A 96 (1999) 10152-10157
17. Kaestner K.H., Katz J., Liu Y., et al. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev 13 (1999) 495-504
18. Ang S.L., and Rossant J. HNF-3 beta is essential for node and notochord formation in mouse development. Cell 78 (1994) 561-574
19. Sasaki H., and Hogan B.L. HNF-3 beta as a regulator of floor plate development. Cell 76 (1994) 103-115
20. Gao N., White P., Doliba N., et al. Foxa2 controls vesicle docking and insulin secretion in mature beta cells. Cell Metab 6 (2007) 267-279
21. Sund N.J., Vatamaniuk M.Z., Casey M., et al. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. Genes Dev 15 (2001) 1706-1715
22. Sund N.J., Ang S.L., Sackett S.D., et al. Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte. Mol Cell Biol 20 (2000) 5175-5183
23. Gao N., LeLay J., Vatamaniuk M.Z., et al. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev 22 (2008) 3435-3448
24. el Marjou F., Janssen K.P., Chang B.H., et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39 (2004) 186-193
25. Gupta R., Gao N., Gorski R.K., et al. Expansion of adult beta-cell mass in response to increased metabolic demand is dependent on HNF-4alpha. Genes Dev 21 (2007) 756-769
26. Lee C.S., Sund N.J., Bhr R., et al. Foxa2 is required for the differentiation of pancreatic alpha-cells. Dev Biol 278 (2005) 484-495
27. Qi Y., Nie Z., Lee Y.S., et al. Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55 (2006) 3083-3090
28. Nagy T.R., and Clair A.L. Precision and accuracy of dual-energy x-ray absorptiometry for determining in vivo body composition of mice. Obes Res 8 (2000) 392-398
29. Friedman J.R., Le P.P., Peiris T.H., et al. Orthogonal analysis of C/EBPbeta targets in vivo during liver proliferation. Proc Natl Acad Sci U S A 101 (2004) 12986-12991
30. Lai E., Prezioso V.R., Tao W.F., et al. Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that is homologous to the Drosophila homeotic gene fork head. Genes Dev 5 (1991) 416-427
31. Hiemisch H., Schutz G., and Kaestner K.H. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis. EMBO J 16 (1997) 3995-4006
32. van der Sluis M., Vincent A., Bouma J., et al. Forkhead box transcription factors Foxa1 and Foxa2 are important regulators of Muc2 mucin expression in intestinal epithelial cells. Biochem Biophys Res Commun 369 (2008) 1108-1113
33. Mashimo H., Wu D.C., Podolsky D.K., et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274 (1996) 262-265
34. Gauthier B.R., Schwitzgebel V.M., Zaiko M., et al. Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements. Mol Endocrinol 16 (2002) 170-183
35. Skipper M., and Lewis J. Getting to the guts of enteroendocrine differentiation. Nat Genet 24 (2000) 3-4
36. Wang M., and Drucker D.J. The LIM domain homeobox gene isl-1 is a positive regulator of islet cell-specific proglucagon gene transcription. J Biol Chem 270 (1995) 12646-12652
37. Hill M.E., Asa S.L., and Drucker D.J. Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription. Mol Endocrinol 13 (1999) 1474-1486
38. Leonard J., Serup P., Gonzalez G., et al. The LIM family transcription factor Isl-1 requires cAMP response element binding protein to promote somatostatin expression in pancreatic islet cells. Proc Natl Acad Sci U S A 89 (1992) 6247-6251
39. Van der Sluis M., De Koning B.A., De Bruijn A.C., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131 (2006) 117-129
40. Velcich A., Yang W., Heyer J., et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 295 (2002) 1726-1729
41. Bartman A.E., Sanderson S.J., Ewing S.L., et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 80 (1999) 210-218
42. Sander M., Neubuser A., Kalamaras J., et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11 (1997) 1662-1673
43. Sharma S.K., Leinemann U., Ratke R., et al. Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans. Biochem J 389 (2005) 831-841
44. Gosmain Y., Avril I., Mamin A., et al. Pax-6 and c-Maf functionally interact with the alpha-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J Biol Chem 282 (2007) 35024-35034
45. Philippe J., Morel C., and Cordier-Bussat M. Islet-specific proteins interact with the insulin-response element of the glucagon gene. J Biol Chem 270 (1995) 3039-3045
46. Ahlgren U., Pfaff S.L., Jessell T.M., et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385 (1997) 257-260
47. Yuan S., and Schoenwolf G.C. Islet-1 marks the early heart rudiments and is asymmetrically expressed during early rotation of the foregut in the chick embryo. Anat Rec 260 (2000) 204-207
48. Dube P.E., and Brubaker P.L. Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. Am J Physiol Endocrinol Metab 293 (2007) E460-E465
49. Liu C.D., Aloia T., Adrian T.E., et al. Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders. Am Surg 62 (1996) 232-236
50. Ho L.T., Pu H.F., Sheu W.J., et al. Inhibition of somatostatin on glucose-induced release of gastric inhibitory polypeptide in rats. Chin J Physiol 30 (1987) 45-53
51. Weckbecker G., Lewis I., Albert R., et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov 2 (2003) 999-1017
52. Lucey M.R. Endogenous somatostatin and the gut. Gut 27 (1986) 457-467
53. Aaboe K., Krarup T., Madsbad S., et al. GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab 10 (2008) 994-1003
54. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 87 (2007) 1409-1439
55. Xu G., Stoffers D.A., Habener J.F., et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48 (1999) 2270-2276
56. Zhou J., Wang X., Pineyro M.A., et al. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48 (1999) 2358-2366
57. Farilla L., Bulotta A., Hirshberg B., et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144 (2003) 5149-5158
58. Buteau J., El-Assaad W., Rhodes C.J., et al. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47 (2004) 806-815
59. Miyawaki K., Yamada Y., Yano H., et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A 96 (1999) 14843-14847
60. Scrocchi L.A., Brown T.J., MaClusky N., et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2 (1996) 1254-1258
61. Pederson R.A., Satkunarajah M., McIntosh C.H., et al. Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice. Diabetes 47 (1998) 1046-1052